Edible flowers bloom with health benefits

Study analyzes the bioactive compounds, antioxidant activities, and aroma profiles of four edible flowers, contributing to their nutritional and health value understanding.

Clinical Trial Data Strategy: Shifting to Innovative Data Collection

Sabrina Steffen, Head of Data Strategy and Innovation for Data Management at IQVIA In drug development, there is a critical focus on protocol design, because

November 21, 2023

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19 | Psychedelic Invest

Revive Therapeutics Ltd. (OTCQB: RVVTF / CSE: RVV / FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical

July 7, 2023

Jupiter Acquisition Files Investor Presentation on Filament Health Deal | Psychedelic Invest

Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE:7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today announced that it intends to complete, subject

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.